NIH-funded research R01 grant

Cytoskeleton and cell suicide: how actin helps control apoptosis

Official title: Cytoskeletal compartmentalization of apoptotic signaling

Funded at University of Connecticut Storrs · NIH-11377641 · Data updated 2026-11-12

A study in human cells will explore how actin filaments and related proteins influence programmed cell death after DNA damage.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Connecticut Storrs
NIH-funded
Lab location1 site (Storrs-Mansfield, United States)
Project startAugust 1, 2024
Project endJuly 31, 2028
Funding year2026
Award (this year)$322,000
NIH project number5R01GM155651-03
Project IDNIH-11377641 on NIH RePORTER

Who could benefit from this research

Could help

Patients with conditions related to apoptotic pathway dysfunction or cancers with altered actin dynamics may benefit from future translational applications.

Less likely to help

Healthy individuals without targeted apoptotic pathway issues are unlikely to directly benefit from this basic science study.

What this research studies

Researchers are examining how the actin cytoskeleton interacts with key apoptosis proteins to control cell death in response to stress. They focus on WASP-family nucleation factors like WASP, JMY, and WHAMM that shape actin filaments and how this affects apoptosome formation and caspase activation. The work aims to map the molecular connections between actin dynamics and the signaling steps that decide whether a cell survives or dies. By understanding these links, we may learn how cells decide to undergo programmed death when DNA is damaged. This could inform strategies to protect healthy cells or selectively target diseased cells in the future.

Why it matters

Potential benefit: Improved insights into how cells decide to die could lead to new approaches for treating diseases where apoptosis goes awry, such as cancer.

How similar studies have gone: Previous work shows that actin dynamics influence apoptotic signaling, supporting potential relevance of this approach.

Where this research is happening

  • University of Connecticut Storrs
    Storrs-Mansfield, United States
    Active

Researchers

  • Principal investigator: Campellone, Kenneth G — University of Connecticut Storrs
  • Study coordinator: Campellone, Kenneth G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.